Structural perturbation and enhancement of the chaperone-like activity of α-crystallin by arginine hydrochloride by Srinivas, Volety et al.
Structural perturbation and enhancement
of the chaperone-like activity of -crystallin
by arginine hydrochloride
VOLETY SRINIVAS, BAKTHISARAN RAMAN, KUNCHALA SRIDHAR RAO,
TANGIRALA RAMAKRISHNA, AND Ch MOHAN RAO
Centre for Cellular & Molecular Biology, Hyderabad 500 007, India
(RECEIVED January 12, 2003; FINAL REVISION March 4, 2003; ACCEPTED March 11, 2003)
Abstract
Structural perturbation of -crystallin is shown to enhance its molecular chaperone-like activity in prevent-
ing aggregation of target proteins. We demonstrate that arginine, a biologically compatible molecule that is
known to bind to the peptide backbone and negatively charged side-chains, increases the chaperone-like
activity of calf eye lens -crystallin as well as recombinant human A- and B-crystallins. Arginine-
induced increase in the chaperone activity is more pronounced for B-crystallin than for A-crystallin.
Other guanidinium compounds such as aminoguanidine hydrochloride and guanidine hydrochloride also
show a similar effect, but to different extents. A point mutation, R120G, in B-crystallin that is associated
with desmin-related myopathy, results in a significant loss of chaperone-like activity. Arginine restores the
activity of mutant protein to a considerable extent. We have investigated the effect of arginine on the
structural changes of -crystallin by circular dichroism, fluorescence, and glycerol gradient sedimentation.
Far-UV CD spectra show no significant changes in secondary structure, whereas near-UV CD spectra show
subtle changes in the presence of arginine. Glycerol gradient sedimentation shows a significant decrease in
the size of -crystallin oligomer in the presence of arginine. Increased exposure of hydrophobic surfaces of
-crystallin, as monitored by pyrene-solubilization and ANS-fluorescence, is observed in the presence of
arginine. These results show that arginine brings about subtle changes in the tertiary structure and significant
changes in the quaternary structure of -crystallin and enhances its chaperone-like activity significantly.
This study should prove useful in designing strategies to improve chaperone function for therapeutic
applications.
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-Crystallin, a multimeric protein of the eye lens, is made
up of two homologous gene products, A- and B-crystal-
lins. B-crystallin is expressed in significant levels in other
tissues, such as heart, kidney, brain, muscle, etc., whereas
A-crystallin is expressed in trace amounts in the spleen
and thymus (Bhat and Nagineni 1989; Dubin et al. 1989;
Iwaki et al. 1989; Kato et al. 1991). B-Crystallin is stress-
inducible and is expressed at elevated levels under certain
disease conditions (Aoyama et al. 1993; Groenen et al.
1994; Renkawek et al. 1994). A- and B-crystallin share
structural and sequence homology with small heat shock
proteins (sHSPs; Ingolia and Craig 1982; Merck et al.
1993). -Crystallin exhibits molecular chaperone-like ac-
tivity in preventing the heat-induced aggregation of other
proteins (Horwitz 1992). It is now established that both A-
and B-crystallin, either in homo-multimeric or hetero-mul-
timeric states, exhibit molecular chaperone-like properties
in preventing aggregation of other proteins (Datta and Rao
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1999; Sun et al. 1999), protecting the enzyme activity from
heat- or other stress-induced inactivation (Hook and Hard-
ing 1997; Hess and Fitzgerald 1998; Marini et al. 2000;
Rajaraman et al. 2001) and in a few cases, assisting the
refolding (Rawat and Rao 1998; Ganea and Harding 2000;
Goenka et al. 2001; Rajaraman et al. 2001).
We have investigated earlier the chaperone-like activity
of -crystallin toward photo-induced aggregation of -crys-
tallin, DTT-induced aggregation of insulin, and the refold-
ing-induced aggregation and -, and -crystallins and dem-
onstrated that it is possible to enhance the chaperone-like
activity of -crystallin (for review, see Rao et al. 1998, 2002
and the references therein). Our results showed that a struc-
tural perturbation by temperature in -crystallin, involving
increased exposure of hydrophobic surfaces, enhanced the
chaperone-like activity of -crystallin severalfold (for re-
view, see Rao et al. 1998, 2002). Subsequent studies from
other laboratories (Das and Surewicz 1995; Palmisano et al.
1995; Borkman et al. 1996) have shown similar results.
Smith et al. (1996) found that hydrophobic regions around
residues 32–37 and 72–75 in A-crystallin and 28–34 in
B-crystallin become solvent-exposed above 30°C. Sharma
et al. (1997, 2000) identified specific target protein-binding
regions, depending on the nature of the target proteins,
which span the -crystallin domain. Evidence has accumu-
lated over the years that temperature regulates the chaper-
oning process in general through structural perturbation of
the chaperone molecules, such as Hsp70 (Craig and Gross
1991; Leung et al. 1996), as well as small heat shock pro-
teins (Rao et al. 1998; Haslbeck et al. 1999; van Montfort et
al. 2001; Gu et al. 2002). Interestingly, the structurally per-
turbed state of Hsp 16.3 at low concentrations of guanidine
hydrochloride (Gdn.HCl) has also been shown to exhibit
enhanced chaperone-like activity (Yang et al. 1999).
In addition to temperature, we have observed that low
concentrations of the denaturant urea also enhance activity
corroborating our hypothesis (for review, see Rao et al.
1998, 2002). Gdn.HCl has been shown to enhance the chap-
erone-like activity of -crystallin (Das and Liang 1997).
Loss or decreased chaperone function appears to be a mo-
lecular basis for a growing number of diseases. If biologi-
cally compatible small molecules could be used to cause a
structural perturbation and enhance the chaperone-like ac-
tivity of -crystallin, they would be of therapeutic signifi-
cance. We, therefore, set out to investigate the effect of the
biologically compatible small molecule Arg.HCl on the
chaperone-like, anti-aggregating activity of -crystallin.
Guanidinium salts, including Arg.HCl, are known to bind to
the peptide backbone as well as side chains of negatively
charged amino acids and tryptophan (Arakawa and Ti-
masheff 1984; Timasheff and Arakawa 1988; Lin and Ti-
masheff 1996).
The chaperone-like activity of -crystallin in preventing
aggregation of other proteins is particularly important in the
context of the eye lens in maintaining its transparency. Our
results show that Arg.HCl can enhance the chaperone-like
activity of bovine eye lens -crystallin as well as the re-
combinant human A- and B-crystallins severalfold. More
interestingly, it can also enhance activity of the mutant B-
crystallin (R120G-B) that causes desmin-related myopa-
thy and congenital cataract (Vicart et al. 1998), perhaps
because of its decreased activity (Kumar et al. 1999). Our
results with guanidinium compounds, such as Arg.HCl and
AGdn.HCl, show that enhanced activity of -crystallin
might be attributable to altered tertiary and quaternary struc-
ture.
Results and Discussion
Structural perturbation of -crystallin leads to a severalfold
increase in its chaperone-like activity (for review, see Das
and Surewicz 1995; Smith et al. 1996; Rao et al. 1998,
2002). Here, we investigate whether some biologically com-
patible compounds, such as Arg.HCl, AGdn.HCl, and
Gdn.HCl, can achieve structural perturbation of -crystallin
and influence its chaperone-like activity. We used DTT-
induced aggregation of insulin at 37°C as a model system
(Fig. 1). -Crystallin prevented the aggregation of insulin
partially (∼36%) at a 1:2 (wt/wt) ratio of -crystallin:insulin
(Fig. 1A). Figure 1B shows that at the same weight ratio,
-crystallin prevents the aggregation of insulin completely
in the presence of 200 mM Arg.HCl. Arg.HCl alone does
not prevent the aggregation of insulin; on the contrary, we
observed that it leads to its significantly increased aggrega-
tion. Despite this effect of Arg.HCl on the aggregation of
insulin, -crystallin in the presence of Arg.HCl showed
complete prevention of aggregation. This result shows that
Arg.HCl increases the chaperone-like activity of -crystal-
lin significantly. The observed increase in the activity is
dependent on Arg.HCl concentration, indicating a dose-de-
pendent interaction of Arg.HCl with -crystallin (Fig. 1C;
open circles).
Eye lens -crystallin is a heteromultimeric protein com-
posed of two types of subunits—A- and B-crystallin.
Both A- and B-crystallin form homomultimers; however,
they exhibit differences in their chaperone-like activities as
well as structural stability (Datta and Rao 1999; Sun et al.
1999; Reddy et al. 2000). To investigate the possible dif-
ferences in the Arg.HCl-induced increase in the chaperone-
like activity, we studied the effect of Arg.HCl on the ac-
tivities of recombinant human A- and B-crystallin to-
ward the DTT-induced aggregation of insulin. In
conformity with earlier reports (Datta and Rao 1999; Sun et
al. 1999; Reddy et al. 2000), we found that B-crystallin
was more effective in preventing the aggregation of insulin
than A-crystallin; it almost completely prevented the ag-
gregation of insulin at a 1:2 (wt/wt) ratio of B-crystallin to
insulin. To see the effect of Arg.HCl on their chaperone-like
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activities, we used a 1:2 ratio (wt/wt) for A-crystallin to
insulin, and a 1:4 (wt/wt) ratio of B-crystallin to insulin, as
B-crystallin is more effective as a chaperone. Figure 1D
shows that Arg.HCl enhanced the activity of both A- and
B-crystallin, the increase being much sharper for B-crys-
tallin than for A-crystallin. The Arg.HCl-induced en-
hancement of the activity of B-crystallin is more pro-
nounced than that of A-crystallin.
We also tested the effect of Lys.2HCl on the chaperone-
like activity of -crystallin. Unlike Arg.HCl, Lys.2HCl did
not enhance the chaperone-like activity of -crystallin to-
ward the DTT-induced aggregation of insulin (Fig. 1B; in-
set). In fact, it reduced the percent protection offered by
-crystallin from 36% in the absence of Lys.2HCl to 17% in
the presence of 100 mM Lys.2HCl. At a concentration of 300
mM Lys.2HCl, the percent protection reduced further to ∼8%.
Incubating -crystallin with low concentrations of
Gdn.HCl (0.8–1.0 M) increases the exposure of its hydro-
phobic surfaces with an accompanying enhancement in its
chaperone-like activity (Das and Liang 1997). Inomata et al.
(2000) showed that aminoguanidine, when fed orally to
Shumiya cataract rats—a hereditary cataract model in which
lens opacity appears spontaneously in the nuclear and peri-
nuclear portions at 11–12 weeks of age—inhibited the
opacification of the lens. Aminoguanidine was also found to
inhibit cataract formation in diabetic rats (Swamy et al.
1996). We, therefore, compared the effect of Arg.HCl,
Gdn.HCl, and AGdn.HCl on the chaperone-like activity of
-crystallin. Figure 1C shows that Arg.HCl and Gdn.HCl
are comparable in their ability to enhance the activity of
-crystallin. AGdn.HCl also enhanced the activity of
-crystallin, but to a lesser extent (Fig.1C).
To find out whether ArgHCl-induced increase in chaper-
one-like activity of -crystallin is also observed with other
protein aggregation systems, we have investigated the effect
of -crystallin incubated with Arg.HCl on the thermally
(43°C) induced aggregation of -crystallin. -Crystallin, at
a 1:4 (wt/wt) ratio of - to -crystallin, prevented the ag-
gregation of -crystallin to the extent of 53%. On preincu-
bation with 100 mM Arg.HCl, the protective ability of
-crystallin increased to ∼81%. Similar Arg.HCl-induced
enhancement of the chaperone-like activity of -crystallin is
observed toward DTT-induced aggregation of -lactalbu-
min at pH 6.5 (data not shown).
Figure 1. Effect of various additives on the chaperone-like activity of -crystallin (0.1mg/mL) toward DTT-induced aggregation of
insulin (0.2mg/mL) at 37°C. (A) Insulin in the absence (open circles) and in the presence of calf eye lens -crystallin (filled circles).
(B) Effect of Arg.HCl. Aggregation of insulin in buffer containing 200 mM Arg.HCl (open triangles); aggregation of insulin in the
presence of -crystallin (0.1 mg/mL) and 200 mM Arg.HCl (filled triangles). Symbols represent different curve types and not data
points. (Inset) Effect of Lys.2HCl. Insulin + 100 mM Lys2HCl (open circles), -crystallin + Insulin + 100 mM Lys2HCl (filled circles),
Insulin + 300 mM Lys2HCl (solid line), -crystallin + insulin + 300 mM Lys2HCl (broken line). (C) Effect of various concentrations
of Arg.HCl (open circles), Gdn.HCl (filled circles), and AGdn.HCl (triangles). (D) Effect of Arg.HCl on the chaperone-like activity
of recombinant human A- and B-crystallins toward the DTT-induced aggregation of insulin at 37°C. Percent protection offered by
0.1 mg/mL A-crystallin (open circles), and 0.05 mg/mL B-crystallin (filled circles), toward the aggregation of insulin (0.2 mg/mL)
as a function of Arg. HCl concentration.
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We have shown earlier that structural perturbation be-
yond 30°C increases the chaperone-like activity of -crys-
tallin (Rao et al. 1998, 2002). To find out if arginine can
mimic the effect of elevated temperature in enhancing the
chaperone-like activity of -crystallin, we investigated the
effect of Arg.HCl on the chaperone-like activity of -crys-
tallin at 25°C and found that at a concentration of 300 mM,
Arg.HCl almost completely prevented the aggregation of
insulin. AGdn.HCl also showed a similar effect on the ac-
tivity of -crystallin at 25°C, but to a lesser extent (data not
shown). This result suggests that Arg.HCl can mimic tem-
perature-effect in enhancing the chaperone-like activity of
-crystallin to some extent.
Our earlier studies (for review, see Rao et al. 1998, 2002)
and studies from other laboratories (Das and Surewicz
1995; Palmisano et al. 1995; Borkman et al. 1996; Smith et
al. 1996) have shown that structural perturbation of -crys-
tallin leads to increased exposure of hydrophobic surfaces.
Hydrophobic interactions have a crucial role in the recog-
nition between chaperones and partially unfolded proteins.
We have investigated the accessibility of the hydrophobic
surfaces of -crystallin as a function of Arg.HCl concen-
tration by solubilizing the hydrophobic fluorophore, pyrene.
Pyrene is sparingly soluble in water. In the presence of
-crystallin (0.3 mg/mL), there is a 4.2-fold increase in the
solubility of pyrene at 37°C. In the concentration range
studied, Arg.HCl alone does not increase the solubility of
pyrene significantly. Pyrene-solubilization by -crystallin,
however, is found to be significantly more in the presence of
Arg.HCl than in its absence. The -crystallin-solubilized
fraction of pyrene (see Materials and Methods) increased
progressively with increase in Arg.HCl concentration (Fig.
2A). These results suggest that there is an increase in the
exposure of hydrophobic surfaces of -crystallin in the
presence of Arg.HCl. We have investigated this aspect fur-
ther using ANS, a fluorophore that binds to and reports on
the hydrophobic surfaces of a protein (Stryer 1965). In the
presence of Arg.HCl, the binding of ANS to -crystallin
increased until the concentration of Arg.HCl reached 100
mM (Fig. 2B). At this concentration of Arg.HCl, there was
∼38% increase in the fluorescence intensity of ANS at the
emission maximum. Beyond this concentration of Arg.HCl,
there was a marginal drop in the fluorescence intensity at
the emission maximum (Fig. 2B). The pyrene-solubilization
studies, as well as the ANS-binding studies, show that
Arg.HCl increases the accessible hydrophobic surfaces of
-crystallin. We studied structural changes in -crystallin
further using intrinsic fluorescence, near- and far-UV CD
spectroscopy, and glycerol density gradient centrifugation.
The intrinsic tryptophan fluorescence spectrum of -crys-
tallin did not change considerably in the presence of
Arg.HCl, suggesting that there is no significant change in
the tryptophan environment. The near-UV CD profiles of
-crystallin in the presence of increasing concentrations of
Arg.HCl show some differences in the region of 270–290
nm (Fig. 3A) suggesting subtle conformational changes at
the tertiary structural level. As L-Arg.HCl gives a strong
signal in the far-UV region below 230 nm, we used DL-
Arg.HCl to perform far-UV CD studies. The far-UV CD
spectra of -crystallin in the absence and the presence of
various concentrations of Arg.HCl almost overlap, with a
minor change in the lower wavelength region (Fig. 3B). The
minima, however, remain unchanged, suggesting that the
secondary structure of -crystallin, largely -sheet, is not
altered in the presence of DL-Arg.HCl. To assess changes in
the quaternary structure of the protein, if any, we performed
sedimentation experiments through a 10%–40% glycerol
gradient in the absence and the presence of 300 mM
Arg.HCl. Figure 4 shows significant decrease in the size of
-crystallin in the presence of Arg.HCl. We also used al-
dolase, catalase, and thyroglobulin as molecular mass stan-
dards and estimated the molecular mass of -crystallin. Our
results show that molecular mass of -crystallin, which is
Figure 2. (A) Solubilization of pyrene by -crystallin as a function of
concentration of Arg.HCl at 37°C. SA − Ab, SArgAarg − AbArg,
where Ab, AbArg, A, and Aarg are the absorbance values at 338 nm of the
pyrene solubilized in buffer alone, buffer containing arginine, -crystallin,
and -crystallin in the presence of arginine, respectively. S represents the
solubility of pyrene by -crystallin and SArg represents the solubility of
pyrene by -crystallin in the presence of Arg.HCl. (B) Relative fluores-
cence intensity of ANS bound to -crystallin in the presence of increasing
concentrations of Arg.HCl at 37°C.
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estimated to be ∼700 kD in the absence of Arg.HCl, is
significantly decreased in the presence of Arg.HCl (∼360
kD). The half-width of the profile of -crystallin in the
presence of Arg.HCl is significantly less (6.25 x-axis units)
than that in its absence (8.75 x-axis units), indicating that
the polydispersity of the protein is also decreased in the
presence of Arg.HCl. We also observed a similar decrease
in the size of the molecule as well as the half-width of the
profiles of A- and B-crystallin (data not shown). There-
fore, our results show that Arg.HCl can bring about subtle
changes in the tertiary structure and significant changes in
the quaternary structure of either the homo-multimers or the
hetero-multimers of A- and B-crystallin. Such changes
also lead to increased chaperone-like activity of -crystal-
lin. We have also investigated the effect of aminoguanidine
on the quaternary structure of -crystallin by the glycerol
gradient sedimentation. The estimated molecular mass of
-crystallin in the presence of 300 mM AGdn.HCl is 575
kD. This shows that AGdn.HCl also brings about changes in
the quaternary structure and reduction in the molecular mass
of -crystallin, however, to a lesser extent compared with
Arg.HCl.
Mutations in A- and B-crystallin at the conserved ar-
ginine residues 116 and 120, respectively, are known to
affect structure and chaperone-like activity in vitro ( Bova et
al. 1999; Kumar et al. 1999). These mutations are known to
result in congenital cataract and desmin-related myopathy
(Litt et al. 1998; Vicart et al. 1998). It would be of interest
to investigate in this context whether the additive Arg.HCl
can restore/increase the chaperone-like activity of these mu-
tants. Interestingly, increasing concentrations of the additive
Arg.HCl increase the protective effect of R120G B-crys-
tallin toward the DTT-induced aggregation of insulin at
37°C, the extent of protection being ∼75% at 300 mM
Arg.HCl. Even 500 mM Arg.HCl did not enhance the ac-
tivity of R116C A-crystallin, however (data not shown).
Earlier studies from our laboratory have shown that R120G
B-crystallin assembles into multimers with slightly in-
creased molecular mass compared with the wild-type B-
crystallin, whereas R116C A-crystallin forms very large
(800–2000 kD), polydisperse, multimers (Kumar et al.
1999). It is not clear whether such difference in the multi-
meric nature of these mutants in some way leads to the
observed differences in the Arg.HCl-induced effects on
chaperone-like activity. As mentioned earlier, Figure 1D
shows that the extent of Arg.HCl-induced increase in the
chaperone activity of A-crystallin is less than that of B-
crystallin. Therefore, these results suggest that the wild-type
and mutant A-crystallin, in general, are less sensitive to-
ward Arg.HCl-induced changes in structure and function.
While the exact mechanism of the interaction of Arg.HCl
with -crystallin is not clear, our study shows that in the
Figure 3. Circular dichroism spectra of -crystallin in the presence and in
the absence of Arg HCl at 37°C. (A) Near-UV CD spectra. (B) Far-UV CD
spectra. -Crystallin in Buffer A alone (curve 1) and the buffer containing
100 mM (curve 2), 200 mM (curve 3), and 300 mM (curve 4) Arg.HCl. To
record far UV-CD spectra, DL-Arg.HCl was used. ([]MRM) Mean residue
mass ellipticity.
Figure 4. Sedimentation of the Arg.HCl-treated (filled circles) and un-
treated (open circles)-crystallin through a linear glycerol gradient (10%–
40%). The samples were incubated at 37°C for 2 h before loading on to the
gradient. The positions of proteins used for standard molecular masses are
also indicated. (a) Aldolase (158 kD); (b) catalase (232 kD); (c) thyroglob-
ulin (669 kD). See Materials and Methods for details.
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presence of Arg.HCl, -crystallin undergoes subtle tertiary
structural changes and significant quaternary structural
changes accompanied by increase in the accessible hydro-
phobic surfaces of the protein. These structural changes
result in a significant enhancement in the chaperone-like
activity of -crystallin. The fact that lysine hydrochloride
could not enhance the chaperone-like activity of -crystal-
lin, whereas Arg.HCl and other guanidinium compounds,
such as Gdn.HCl and AGdn.HCl, could markedly increase
its chaperone-like activity (but to different extents) shows
selective interaction of the guanidinium group in arginine
with -crystallin. We have also observed a change in the
near-UV CD spectrum and size of -crystallin in the pres-
ence of Lys.2HCl (data not shown), indicating that
Lys.2HCl can also interact with the protein. It failed to
increase the chaperone-like activity of -crystallin, how-
ever; rather it decreased the activity. Therefore, it appears
that the mode of interaction of Lys.2HCl or the consequence
of the interaction with -crystallin is either distinctly dif-
ferent from that of the guanidinium compounds, such as
Arg.HCl and AGdn.HCl or the -crystallin-target protein
complex is unstable and aggregation-prone in the presence
of Lys.2HCl. It is also known that Arg.HCl and Lys.2HCl
exhibit opposite effects on the stability of globular proteins
(Lin and Timasheff 1996) though both these amino acids
can interact with peptide groups and negatively charged side
chains of proteins (Arakawa and Timasheff 1984; Ti-
masheff and Arakawa 1988; Lin and Timasheff 1996).
Growing evidences suggest that some small molecules
modulate chaperone function (Clark and Huang 1996; Vozi-
yan et al. 2000; Diamant et al. 2001; Song and Chuang
2001; Tieman et al. 2001). Osmolytes, such as glycinebeta-
ine, proline, and glycerol, have been shown to activate the
molecular chaperones GroEL, DnaK, and ClpB (Diamant et
al. 2001). The cellular metabolite pantethine has been
shown to increase the anti-aggregation activity of -crys-
tallin (Clark and Huang 1996). Osmolytes, such as sarco-
sine, potassium glutamate, and trimethylamine-N-oxide,
can significantly enhance the folding yields of chaperone-
bound glutamine synthetase (Voziyan et al. 2000). Some
osmolytes can themselves enhance the folding of the target
proteins and also help in release and folding of chaperone-
bound target proteins (Voziyan et al. 2000; Song and
Chuang 2001; Tieman et al. 2001). Synergistic effects are
also observed in some cases (Voziyan et al. 2000). In such
a situation, finding out the specific effect(s) of osmolytes on
target protein, chaperone, and the chaperone-target protein
complex individually becomes difficult. Our study shows
that the insulin aggregation system is particularly useful in
this context. Arginine is known to reduce aggregation and
enhance the refolding yields of some enzymes (Rudolph and
Lilie 1996). Our results, however, show that arginine does
not decrease the aggregation of insulin and in fact increases
the aggregation of insulin. The ability of -crystallin to
prevent this aggregation is increased in the presence of ar-
ginine. Our results also show that arginine can bring about
changes in tertiary and quaternary structure of -crystallin
leading to increased exposure of hydrophobic surfaces.
These results, therefore, suggest that the arginine-induced
changes in -crystallin are important factors, which contrib-
ute to the observed arginine-induced enhancement in the
chaperone-like activity.
Therefore, our study shows that Arg.HCl, a biologically
compatible amino acid, can significantly improve the chap-
eroning function of -crystallin by specific interactions with
the protein. Our study also demonstrates that aminoguani-
dine (AGdn.HCl), which has been shown previously to in-
hibit lens opacification in animal models (Swamy et al.
1996; Inomata et al. 2000), also increases the chaperone-
like activity of -crystallin. Aminoguanidine, lysine, and
other amino acids can inhibit glycation and therefore confer
protection against diabetes-induced lens opacification
(Swamy et al. 1996; Sulochana et al. 1998). It is also pos-
sible that the enhancement of chaperone-like activity of
-crystallin is one of the probable mechanisms, if not the
sole mechanism, involved in the inhibition of lens opacifi-
cation by aminoguanidine in some animal models. Arginine
might confer beneficial effects against lens opacification
because, as our results show, it is more effective in increas-
ing the chaperone-like activity of -crystallin than amino-
guanidine. We are currently testing this possibility in animal
models. In addition, arginine may offer other beneficial ef-
fects, as it is the substrate for enzymatic production of nitric
oxide and is believed to confer cardiovascular protection
(Suematsu et al. 2001). It exhibits antioxidant properties in
scavenging superoxide radicals (Haklar et al. 1998). There-
fore, Arg.HCl is one of the promising agents to exhibit
pleotropic beneficial effects in general health and disease
resistance.
Materials and methods
Materials
Arg.HCl, DL-Arg.HCl, AGdn.HCl, Lys.2HCl, bovine insulin, and
pyrene were obtained from Sigma Chemical Company. ANS was
obtained from Aldrich Chemical Company. Gdn.HCl was pur-
chased from Serva, Germany. All other chemicals used in the
studies were of Analytical Reagent grade.
Methods
Preparation of -crystallin and -crystallin
-Crystallin was purified from calf eye lenses as previously de-
scribed (Raman & Rao 1994). Recombinant human A- and B-
crystallins were prepared by cloning, overexpression in Escherich-
ia coli and purification as described earlier (Kumar et al. 1999).
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-Crystallin was purified from guinea pig eye lenses as described
by Rao and Zigler (1992).
Assays for chaperone-like activity of -crystallin
Aggregation of insulin was initiated by reducing the disulfide
bonds as described below. All assays to measure chaperone-like
activity were carried out in 10 mM phosphate buffer, pH 7.4,
containing 100 mM NaCl (Buffer A). The buffer alone or the
buffer containing -crystallin (0.1 mg/mL), A-crystallin (0.1 mg/
mL) or B-crystallin (0.025 mg/mL) and the required amount of
Arg.HCl was equilibrated at 37°C for 3 min with constant stirring
in the sample holder using a Julabo thermostated water bath. In-
sulin (0.2 mg/mL) was then added and reduction of insulin was
initiated by adding 20 L of 1 M DTT to 1.2 mL of the sample.
The extent of aggregation of insulin was measured as a function of
time by monitoring 90° scattering at 465 nm using a Hitachi
F-4000 fluorescence spectrophotometer. The excitation and emis-
sion band passes were set at 3 nm.
Buffer A either in the absence or in the presence of -crystallin
(0.025 mg/mL) and required concentrations of Arg.HCl was incu-
bated at 43°C for 3 min in the thermostated cuvette holder of the
fluorescence spectrophotometer. -Crystallin was then added to a
final concentration of 0.1mg/mL. The extent of aggregation was
monitored as a function of time by measuring the scattering of 465
nm light as described above.
The percentage protection was calculated using the equation
([Ic − I]/Ic) ✕ 100, where Ic and I are the intensities of light
scattered by control (target protein alone) and by the sample (plus
-crystallin), respectively. In the cases where additives were
added, the Ic was the scattering intensity of the control in the
presence of the additive and I, the scattering intensity of this
sample with additive in the presence of -crystallin.
Solubilization of pyrene
-Crystallin solution (0.3 mg/mL in Buffer A) in the absence or
the presence of varying concentrations of Arg.HCl was stirred with
1 mM pyrene suspension at 37°C for 30 min. The mixture was
centrifuged at 14,000 rpm for 5 min to remove the unsolubilized
pyrene. Optical density of the supernatant was measured at 338 nm
in a Hitachi-330 UV-Visible spectrophotometer. Solubility of py-
rene in Arg.HCl solutions alone was also measured using the
above procedure. The solubilization of pyrene by -crystallin
alone or by -crystallin in the presence of varying concentrations
of Arg.HCl was obtained after correcting for the appropriate
blanks. To assess the extent of increase in pyrene solubilization by
-crystallin in the presence of Arg.HCl, the ratio of pyrene solu-
bilized by -crystallin in the presence of a given Arg.HCl concen-
tration (Sarg) to pyrene solubilized by -crystallin alone (S) was
plotted as a function of Arg.HCl concentration.
Circular dichroism studies
Circular dichroism spectra were recorded using a Jasco J-715
Spectropolarimeter. All spectra are the average of four accumula-
tions. Far- and near-UV CD spectra of -crystallin (1.5 mg/mL) in
the absence and the presence of various concentrations of Arg.HCl
were recorded at 37°C using thermostated 0.01 cm and 1 cm
pathlength cuvettes, respectively. All spectra were corrected for
the respective blanks. As L-arginine hydrochloride shows a large
CD signal below 230 nm, we used DL-Arg.HCl to record the
far-UV CD spectra of -crystallin.
Fluorescence studies
Fluorescence spectra were recorded using a Hitachi F-4000 Fluo-
rescence Spectrophotometer equipped with a thermostated cuvette
holder. All the studies were performed at 37°C. All spectra were
recorded in the corrected spectrum mode. The intrinsic tryptophan
fluorescence spectra of -crystallin (0.2 mg/mL) in Buffer A alone
or in the buffer containing the required concentrations of Arg.HCl
were recorded by exciting the sample at 295 nm with the excitation
and emission band passes set at 3 nm.
To study the binding of the hydrophobic probe, ANS, to -crys-
tallin, 12 L of 10 mM methanolic solution of ANS was added to
1.2 mL of a 0.5 mg/mL solution of -crystallin in Buffer A alone
or in the buffer containing the required concentrations of Arg.HCl.
The samples were excited at 365 nm and emission spectra recorded
from 400–600 nm at 37°C. The excitation and emission band
passes were set at 3 and 5 nm, respectively. All spectra were
corrected for the respective blanks. Spectra were recorded in the
corrected spectrum mode.
Glycerol gradient centrifugation
Glycerol gradient centrifugation was carried out essentially as de-
scribed by Lambert et al. (1999). -Crystallin, A- or B-crystal-
lin (2 mg/mL) was incubated in 50 mM Tris HCl buffer (pH 7.4)
containing 100 mM NaCl, 1 mM EDTA alone or in the presence
of 300 mM Arg.HCl for 2 h at 37°C. The samples (0.5 mL) were
loaded on top of a 12 mL linear gradient of glycerol (10%–40%)
made in 50 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl
and 1 mM EDTA. Arg.HCl-treated -crystallin samples were run
in the gradient also containing 300 mM Arg.HCl. The tubes were
centrifuged for 18 h at 30,000 rpm in a Beckman SW41 rotor at
4°C. Fractions (0.3 mL) were withdrawn from the top using a
Haake-Buchler Auto Densi-Flow IIC gradient former/remover and
optical density at 280 nm of the fractions were measured using a
Shimadzu UV- 1601 spectrophotometer. To estimate the molecular
masses, of the -crystallin samples, proteins with defined molecu-
lar masses, such as thyroglobulin (669 kD), catalase (232 kD), and
aldolase (158 kD) were used. We have also studied the effect of
aminoguanidine on the size of -crystallin using the similar pro-
cedure described above, except the incubation time was 20 min.
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